Vertex Pharmaceuticals Incorporated
GCN2 inhibitors and uses thereof
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
28 Jan 2019
Issue date:
6 Oct 2020